TRASTUZUMAB IN METASTATIC BREAST CANCER: A SYSTEMATIC REVIEW OF COST-EFFECTIVENESS ANALYSES

被引：0
|
作者：
Andrade, T. S. D. [1 ]
Mosegui, G. B. G. [1 ]
Miranda, E. S. [1 ]
Souza, T. F. G. D. [1 ]
Vianna, C. M. D. M. [2 ]
Silva, F. V. C. [3 ]
机构：
[1] Univ Fed Fluminense, Niteroi, RJ, Brazil
[2] Univ Estado Rio de Janeiro, BR-20550011 Rio De Janeiro, Brazil
[3] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.2044
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
下载
收藏
页码：A687 / A687
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF ADJUVANT TRASTUZUMAB FOR EARLY BREAST CANCER IN ASIA: A SYSTEMATIC REVIEW
    Rafar, Abdul N. R.
    Neoh, C. F.
    Othman, M. F.
    Hong, Y. H.
    VALUE IN HEALTH, 2018, 21 : S14 - S14
  • [2] Cost-Effectiveness of Trastuzumab as Adjuvant Therapy for Early Breast Cancer: A Systematic Review
    Chan, Agnes L. F.
    Leung, Henry W. C.
    Lu, Chin-Li
    Lin, Shun Jin
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (02) : 296 - 303
  • [3] An updated systematic review of the cost-effectiveness of therapies for metastatic breast cancer
    Gogate, Anagha
    Rotter, Jason S.
    Trogdon, Justin G.
    Meng, Ke
    Baggett, Christopher D.
    Reeder-Hayes, Katherine E.
    Wheeler, Stephanie B.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 174 (02) : 343 - 355
  • [4] An updated systematic review of the cost-effectiveness of therapies for metastatic breast cancer
    Anagha Gogate
    Jason S. Rotter
    Justin G. Trogdon
    Ke Meng
    Christopher D. Baggett
    Katherine E. Reeder-Hayes
    Stephanie B. Wheeler
    Breast Cancer Research and Treatment, 2019, 174 : 343 - 355
  • [5] Cost-Effectiveness of Adjuvant Trastuzumab Therapy for Early Breast Cancer in Asia: A Systematic Review
    Rafar, Noor Razilah Abdul
    Hong, Yet Hoi
    Wu, David Bin-Chia
    Othman, Muhamad Faiz
    Neoh, Chin Fen
    VALUE IN HEALTH REGIONAL ISSUES, 2019, 18 : 151 - 158
  • [6] Cost-effectiveness Analysis of Pertuzumab With Trastuzumab in Patients With Metastatic Breast Cancer
    Dai, Wei Fang
    Beca, Jaclyn M.
    Nagamuthu, Chenthila
    Liu, Ning
    de Oliveira, Claire
    Earle, Craig C.
    Trudeau, Maureen
    Chan, Kelvin K. W.
    JAMA ONCOLOGY, 2022, 8 (04) : 597 - 606
  • [7] The clinical effectiveness and cost-effectiveness of gemcitabine for metastatic breast cancer: a systematic review and economic evaluation
    Takeda, A. L.
    Jones, J.
    Loveman, E.
    Tan, S. C.
    Clegg, A. J.
    HEALTH TECHNOLOGY ASSESSMENT, 2007, 11 (19) : 1 - +
  • [8] Cost-effectiveness of trastuzumab in metastatic breast cancer: Mainly a matter of price in the EU?
    Garattini, Livio
    van de Vooren, Katelijne
    Curto, Alessandro
    HEALTH POLICY, 2015, 119 (02) : 212 - 216
  • [9] Cost-effectiveness analyses of breast cancer medications use in developing countries: a systematic review
    Al-Ziftawi, Nour Hisham
    Shafie, Asrul Akmal
    Ibrahim, Mohamed Izham Mohamed
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, 21 (04) : 655 - 665
  • [10] Cost-effectiveness of HER2 testing and trastuzumab therapy for metastatic breast cancer
    Lidgren, Mathias
    Wilking, Nils
    Jonsson, Bengt
    Rehnberg, Clas
    ACTA ONCOLOGICA, 2008, 47 (06) : 1018 - 1028
12345